Literature DB >> 11910862

[Reproducible drug exanthema to terbinafine with characteristic distribution of baboon syndrome].

J M Weiss1, M Mockenhaupt, E Schöpf, J C Simon.   

Abstract

A 26 year old patient developed a fixed drug eruption located on his hands, inguinal and gluteal areas following oral treatment of onychomycosis with terbinafine. The rash showed the characteristic distribution of the "baboon-syndrome", so-named because of the red perianal region of the baboon. Although epicutaneous testing revealed no positive reaction, the rash could be induced in identical sites by oral administration of terbinafine. As the underlying pathomechanism for the "baboon-syndrome" a systemically induced allergic contact dermatitis has been suggested. In addition to the described substances, e.g. mercury, amoxicillin, ampicillin, heparin and nickel, this is the first report of "baboon syndrome" induced by terbinafine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11910862     DOI: 10.1007/s001050170022

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  3 in total

1.  [Facial pigmentation following therapy with terbinafine].

Authors:  K Breuer; B Völker; R Gutzmer; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 2.  Rare drug allergies: Review on prevalence and test procedures.

Authors:  R Treudler; J C Simon
Journal:  Allergol Select       Date:  2017-08-04

Review 3.  Systemic Contact Dermatitis: The Routes of Allergen Entry.

Authors:  Zhouxian Pan; Yongshi Yang; Lishan Zhang; Rui Tang; Christopher Chang; Jinlyu Sun; Xianjie Zhou; Yueping Zeng; Jing Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-02       Impact factor: 8.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.